New Key Statistics Module, Z-Score and F-Score
NAS:CRDF Key Ratios
Market Cap $ M | 241.70 |
Enterprise Value $ M | 180.87 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.47 |
Price/Sales | 570.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.93 |
Beneish M-Score | -3.62 |
10-y EBITDA Growth Rate % | 42.80 |
5-y EBITDA Growth Rate % | 30.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.98 |
EV-to-EBITDA | -4.02 |
PEG | -- |
Shares Outstanding M | 44.68 |
Net Margin (%) | -8,492.01 |
Operating Margin % | -9,305.74 |
Pre-tax Margin (%) | -8,492.01 |
Quick Ratio | 7.41 |
Current Ratio | 7.41 |
ROA % (ttm) | -42.26 |
ROE % (ttm) | -47.42 |
ROIC % (ttm) | -616.78 |
Dividend Yield % | -- |
Altman Z-Score | 6.44 |
Piotroski F-Score | 3.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
CRDF Number of Guru Trades
CRDF Volume of Guru Trades
Gurus Latest Trades with NAS:CRDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRDF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cardiff Oncology Inc Insider Transactions
No Available Data
News about NAS:CRDF
Total 0- 1